ScholarIQanswers from OpenAlex

Inpatient and outpatient treatment patterns of cancer-associated thrombosis in the United States

PaperCitations, authors & open-access status

Inpatient and outpatient treatment patterns of cancer-associated thrombosis in the United States is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Inpatient and outpatient treatment patterns of cancer-associated thrombosis in the United States have?

ScholarIQcitation count

Inpatient and outpatient treatment patterns of cancer-associated thrombosis in the United States has 23 citations in the OpenAlex counts ScholarIQ stores.

When was Inpatient and outpatient treatment patterns of cancer-associated thrombosis in the United States published?

ScholarIQyear

Inpatient and outpatient treatment patterns of cancer-associated thrombosis in the United States has 2020 year in the ScholarIQ index.

What is the open-access status of Inpatient and outpatient treatment patterns of cancer-associated thrombosis in the United States?

ScholarIQoa status

Inpatient and outpatient treatment patterns of cancer-associated thrombosis in the United States has hybrid oa status in the ScholarIQ index.

What is the DOI of Inpatient and outpatient treatment patterns of cancer-associated thrombosis in the United States?

ScholarIQdoi

The DOI for Inpatient and outpatient treatment patterns of cancer-associated thrombosis in the United States is on the source record.

What is the PMID of Inpatient and outpatient treatment patterns of cancer-associated thrombosis in the United States?

ScholarIQpmid

The PMID for Inpatient and outpatient treatment patterns of cancer-associated thrombosis in the United States is on the source record.

What is the OpenAlex record for Inpatient and outpatient treatment patterns of cancer-associated thrombosis in the United States?

ScholarIQopenalex

The OpenAlex for Inpatient and outpatient treatment patterns of cancer-associated thrombosis in the United States is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial